PYC

11.1%

20.0¢ pyc therapeutics limited

will just add both orphan drug and orphan pediatric drug was...

First 15 Last

Share
Profile

Follow
grimloq

701 Posts.

72

12/08/20

13:53

Post #: 46483769
Share

Originally posted by Timbo57: ↑

Some (non-scientific) points I picked up on this morning:
1. Results of rabbit tox studies available in Q4.
2. Efficacy readouts from patient derived models available late Q4.
3. Second eye drug to be introduced this year H2. 3rd drug also in pipeline.
4. Orphan Drug application has been submitted and decision due by end Sept. This has the potential for significant reimbursement of development costs and reduction of approval timeframes.
5. Both rabbit AND monkey efficacy studies available within 6 months.

Comment by Prof Sue Fletcher - We are very excited, we have never had an opportunity to work with such a high quality CPP before.

Looks like a good flow of news in the coming months - starting late September.
I've upgraded from Hold to Buy, due to the range of developments due in short term (orphan drug, 2nd drug, rabbits, efficacy readouts, monkeys) which I anticipate will deliver mostly positive outcomes. I have no idea which way the orphan drug application will swing, but if it is positive then that will be fantastic news. I have been surprised in recent months with the length of the IND approval process. I thought 6-12 months not 12-18. hopefully the orphan drug application can take us closer to 12 months.

Hope this makes sense and is accurate - if anyone else can add or improve this update then please do so.
Timbo

Expand

will just add both orphan drug and orphan pediatric drug was applied for I believe. The pediatric designation could come with expedited review voucher eventually

PYC Price at posting: 12.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

TIG

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

NWH

NRW Holdings inks $109M deal with BHP for works at Jimblebar

RAG

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

SHN

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

A3D

Defence MOU for propulsion systems pushes Aurora Lab shares higher

IMA

Issues emerging as Australian companies tackle critical minerals challenge

CXU

Cauldron Energy reports "excellent" uranium assays in latest drill run

There are more pages in this discussion • 2 more messages in this thread...

First 15 Last

Add PYC (ASX) to my watchlist

(20min delay)
Last 20.0¢		Change 0.020(11.1%)		Mkt cap ! $933.2M

Open	High	Low	Value	Volume
18.0¢	20.5¢	18.0¢	$1.219M	6.294M

Buyers (Bids)

No.	Vol.	Price($)
2	106194	19.5¢

Sellers (Offers)

Price($)	Vol.	No.
20.0¢	184767	1

View Market Depth

No.	Vol.	Price($)
2	106194	0.195
7	220795	0.190
2	67058	0.185
5	176660	0.180
6	182210	0.175

Price($)	Vol.	No.
0.200	184767	1
0.205	1125723	8
0.210	1051194	5
0.215	1154610	6
0.220	1046708	5

Last trade - 16.10pm 11/10/2024 (20 minute delay)

PYC (ASX) Chart

will just add both orphan drug and orphan pediatric drug was...

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Issues emerging as Australian companies tackle critical minerals challenge

Cauldron Energy reports "excellent" uranium assays in latest drill run

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

will just add both orphan drug and orphan pediatric drug was...

Top Stories

Tigers Realm's US$49M sale of Russian assets – to a Kremlin-adjacent billionaire – set to go ahead

NRW Holdings inks $109M deal with BHP for works at Jimblebar

Ragnar impressed by 11.55 metre pegmatite in Sweden, anticipating further mineralisation

Week 41 Wrap: HotCopper asks “Back to Mongolia?” for Elixir; US CPI comes in at 2.4%; eyes still on China

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ASX Market Open: ASX200 to open flattish after Wall Street weakens on hot US inflation data | October 11, 2024

Sunshine Metals kicks off copper gold drilling at Truncheon; Highway East targets

Defence MOU for propulsion systems pushes Aurora Lab shares higher

Issues emerging as Australian companies tackle critical minerals challenge

Cauldron Energy reports "excellent" uranium assays in latest drill run

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News